Duchenne

Duchenne is a severe and progressive form of muscular dystrophy, a genetic disorder characterized by rapid muscle degeneration and weakness.

Why it’s in the news: It is in the news due to the ongoing FDA review and potential rejection of a drug developed by Capricor Therapeutics to treat the condition.

Latest on Duchenne

• Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
• STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection
• STAT+: Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more
• STAT+: FDA expert committee reviews Capricor Therapeutics’ Duchenne drug
• STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
• STAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug

Connections

3 entities linked to Duchenne across the news graph.